Evidence map›Paper›PMID 40678310›Full record

ArticleCurrent health sciences journal

Analysis of Imaging, Pathology and Demographic Data of Lung Cancer Patients Diagnosed in a Tertiary Medical Center in the South-West Region of Romania.

Ovidiu Cîmpeanu, Ilona Mihaela Liliac, Daniel-Nicolae Pirici, Mihai Olteanu, Costin-Teodor Streba

Abstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ovidiu CîmpeanuDoctoral School, University of Medicine and Pharmacy of Craiova, Romania.
Ilona Mihaela LiliacDepartment of Histology, University of Medicine and Pharmacy of Craiova, Romania.
Daniel-Nicolae PiriciDepartment of Histology, University of Medicine and Pharmacy of Craiova, Romania.
Mihai OlteanuDepartment of Pulmonology, University of Medicine and Pharmacy of Craiova, Romania.
Costin-Teodor StrebaDepartment of Pulmonology, University of Medicine and Pharmacy of Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLung cancer is the most common type of primary tumor in both males and females, accounting for significant mortality worldwide. Clear evidence regarding comorbidities and aggravating factors exist, with multiple pathways being cited in recent literature. PATIENTS AND

methodsOur aim was to review relevant sources and demonstrate through an original statistical study that tumor type, location, comorbidities, as well as demographic factors, may play a limited role in the evolution of lung adenocarcinoma. After obtaining ethical clearance, we enrolled consenting lung cancer patients in an observational cross-sectional study, collecting relevant demographic and medical information. Patients were recruited from a single tertiary medical center in Craiova, Romania, between January 2021 and January 2025. We used the Anova and the chi-square tests, considering p values below 0.05 as statistically significant.

resultsWe enrolled 189 patients (143 males, 75.6% of the entire lot), from urban and rural settings (49.7% from urban areas). The mean age was 64.94±10.47 years, with minimal variance when accounting for gender or provenance (Anova test, p>0.05). Most tumors were located in the upper portions of the lungs, with 111 cases, 53.44%. We found that 55.24% of males had tumors of the right lung, while only 39.13% of females had this location. Men had higher COPD rates (79 cases, 55.24%) and only two females (4.34%), p<0.05. However, we found statistically significant more women smokers than men (82.6% women vs. 41.25% of men).

conclusionWe hereby demonstrated that lung cancer remains a significant medical burden for the medical system, with prevalence in both sexes, irrespective of provenance. Most cases were diagnosed between 40 and 65 years, smoking and toxic exposure being predominant.

Indexed as

immunohistochemistryinflammationLung cancer

Identifiers

PMID40678310
PMCPMC12264999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.